WEG KENNETH E 4
4 · AVEO PHARMACEUTICALS INC · Filed Mar 18, 2010
Insider Transaction Report
Form 4
WEG KENNETH E
Director
Transactions
- Conversion
Series D Convertible Preferred Stock
2010-03-17−165,969→ 0 total→ Common Stock (41,492 underlying) - Conversion
Series A Convertible Preferred Stock
2010-03-17−800,000→ 0 total(indirect: By Partnership)→ Common Stock (200,000 underlying) - Conversion
Common Stock
2010-03-17+41,492→ 41,492 total - Conversion
Common Stock
2010-03-17+200,000→ 325,000 total(indirect: By Partnership) - Conversion
Common Stock
2010-03-17+230,769→ 555,769 total(indirect: By Partnership) - Conversion
Series B Convertible Preferred Stock
2010-03-17−923,077→ 0 total(indirect: By Partnership)→ Common Stock (230,769 underlying)
Holdings
- 10,000(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]The Series D Convertible Preferred Stock converted into Common Stock on a 1-for-0.25 basis and had no expiration date.
- [F2]The Series A Convertible Preferred Stock converted into Common Stock on a 1-for-0.25 basis and had no expiration date.
- [F3]The Series B Convertible Preferred Stock converted into Common Stock on a 1-for-0.25 basis and had no expiration date.
- [F4]These shares are held by The Weg Family Limited Partnership. Mr. Weg is a member of The Weg Family Limited Partnership and may be deemed to have voting and investment power over shares held of record by it. Mr. Weg disclaims beneficial ownership over shares held of record by The Weg Family Limited Partnership except to the extent of his pecuniary interest therein.
- [F5]These shares are held by Clearview Venture Partners, LLC. Mr. Weg is a founder and a member of the board of directors of Clearview Venture Partners, LLC and may be deemed to have voting and investment power over shares held of record by it. Mr. Weg disclaims beneficial ownership over shares held of record by Clearview Venture Partners, LLC except to the extent of his pecuniary interest therein.